Antisense oligonucleotides for haematological malignancies.
Cotter
F E
FE
LRF Molecular Haematology Unit, Institute of Child Health, London, UK. f.cotter@ich.ucl.ac.uk
D002318:Cardiovascular Diseases / Q000628:therapy; D020650:Combinatorial Chemistry Techniques; D015195:Drug Design; D005544:Forecasting; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D015723:Gene Library; D015658:HIV Infections / Q000628:therapy; D019337:Hematologic Neoplasms / Q000235:genetics / Q000628:therapy*; D006801:Humans; D016376:Oligonucleotides, Antisense / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*
D016376:Oligonucleotides, Antisense